ARCHIVES

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

This article is from The Cancer Letter archive.

Vol. 07 No. 41 | October 9, 1981

Download PDF Visit The Full Archive

Related Articles

New Edition Of Book On Cancer Rates, Risks, Available

February 28, 1997

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

Institutions Fail To Credit NIH when Patenting discoveries, HHS Says

July 15, 1994

Roswell Park Wins Competition for Organ Systems Coordinating Center

May 18, 1984

ONS Accredited As Approver, Provider Of Continuing Education

April 22, 1988

Herberman Outlines NSABP restructuring In Plan To NCI

May 6, 1994